Breaking News Instant updates and real-time market news.

MRUS

Merus

$16.89 /

-0.4 (-2.31%)

08:37
12/16/19
12/16
08:37
12/16/19
08:37

Merus CEO Ton Logtenberg to step down, Sven Lundberg nominated to succeed

Merus announced that Ton Logtenberg will step down as CEO, President, Principal Financial Officer and Director of the Company on December 31, 2019. The Merus Board of Directors has nominated Dr. Sven Ante Lundberg, currently a non-executive director on the Merus board, to succeed Logtenberg as CEO, President and Principal Financial Officer of Merus. In accordance with Dutch law, the appointment will be voted on during an extraordinary general meeting of shareholders on December 31, 2019. Dr. Logtenberg will remain on as a senior advisor for Merus during the transition over the next year. Bill Lundberg joined Merus' Board of Directors in June 2019, and he brings more than 15 years of experience managing and leading biotechnology research and development along with a background as a medical oncologist.

MRUS Merus
$16.89 /

-0.4 (-2.31%)

11/20/19 Guggenheim
Merus assumed with a Buy at Guggenheim
06/28/19 Roth Capital
Merus initiated with a Buy at Roth Capital
04/12/19 Guggenheim
Merus assumed with a Buy at Guggenheim
04/05/19 Wedbush
Merus price target lowered to $25 from $34 at Wedbush

TODAY'S FREE FLY STORIES

Earnings
Huntsman reports Q3 adj. EPS 32c, consensus 27c » 06:04
10/29/20
10/29
06:04
10/29/20
06:04
HUN

Huntsman

$23.99 /

-0.31 (-1.28%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUN Huntsman
$23.99 /

-0.31 (-1.28%)

HUN Huntsman
$23.99 /

-0.31 (-1.28%)

10/15/20
Fly Intel: Pre-market Movers
10/15/20 Deutsche Bank
Huntsman initiated with a Buy at Deutsche Bank
09/30/20
Fly Intel: Top five analyst upgrades
09/30/20 Morgan Stanley
Huntsman upgraded to Overweight from Equal Weight at Morgan Stanley
HUN Huntsman
$23.99 /

-0.31 (-1.28%)

HUN Huntsman
$23.99 /

-0.31 (-1.28%)

HUN Huntsman
$23.99 /

-0.31 (-1.28%)

Earnings
Vontier sees Q4 core revenue growth in mid-single digits, consensus $790.84M » 06:03
10/29/20
10/29
06:03
10/29/20
06:03
VNT

Vontier

$28.23 /

-0.53 (-1.84%)

Sees Q4 adjusted core…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VNT Vontier
$28.23 /

-0.53 (-1.84%)

VNT Vontier
$28.23 /

-0.53 (-1.84%)

10/26/20 Baird
Vontier initiated with an Outperform at Baird
10/19/20 Rosenblatt
Fortive price target lowered to $68 from $81 at Rosenblatt
10/16/20 Credit Suisse
Vontier initiated with an Outperform at Credit Suisse
10/15/20 Wolfe Research
Vontier initiated with an Outperform at Wolfe Research
VNT Vontier
$28.23 /

-0.53 (-1.84%)

VNT Vontier
$28.23 /

-0.53 (-1.84%)

Hot Stocks
Spotify reports premium subscribers up 27% y/y to 144M in Q3 » 06:03
10/29/20
10/29
06:03
10/29/20
06:03
SPOT

Spotify

$276.35 /

-11.34 (-3.94%)

Spotify said: "Our…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

10/27/20 Morgan Stanley
Spotify price target raised to $300 from $275 at Morgan Stanley
10/27/20 Deutsche Bank
Spotify price target raised to $250 from $240 at Deutsche Bank
10/14/20 Barclays
Spotify price target raised to $320 from $310 at Barclays
10/06/20 Credit Suisse
Sirius XM upgraded to Outperform from Neutral at Credit Suisse
SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

Upgrade
Illinois Tool Works upgraded to Neutral from Underperform at BofA » 06:03
10/29/20
10/29
06:03
10/29/20
06:03
ITW

Illinois Tool Works

$192.48 /

-6.095 (-3.07%)

BofA upgraded Illinois…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITW Illinois Tool Works
$192.48 /

-6.095 (-3.07%)

ITW Illinois Tool Works
$192.48 /

-6.095 (-3.07%)

10/26/20 BMO Capital
Illinois Tool Works price target raised to $225 from $205 at BMO Capital
10/26/20 Wells Fargo
Illinois Tool Works price target raised to $225 from $220 at Wells Fargo
10/26/20 Deutsche Bank
Illinois Tool Works price target raised to $185 from $173 at Deutsche Bank
10/26/20 Citi
Illinois Tool Works price target raised to $211 from $203 at Citi
ITW Illinois Tool Works
$192.48 /

-6.095 (-3.07%)

Initiation
Angi Homeservices initiated with an Outperform at Credit Suisse » 06:02
10/29/20
10/29
06:02
10/29/20
06:02
ANGI

Angi Homeservices

$10.65 /

-0.295 (-2.70%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANGI Angi Homeservices
$10.65 /

-0.295 (-2.70%)

ANGI Angi Homeservices
$10.65 /

-0.295 (-2.70%)

09/24/20 Piper Sandler
Angi Homeservices initiated with a Neutral at Piper Sandler
09/15/20 Jefferies
IAC's key segments saw sequential acceleration in August, says Jefferies
09/14/20 KeyBanc
Angi Homeservices initiated with an Overweight at KeyBanc
09/14/20 KeyBanc
Angi Homeservices initiated with an Overweight at KeyBanc
ANGI Angi Homeservices
$10.65 /

-0.295 (-2.70%)

ANGI Angi Homeservices
$10.65 /

-0.295 (-2.70%)

ANGI Angi Homeservices
$10.65 /

-0.295 (-2.70%)

Hot Stocks
Spotify reports Q3 total MAUs up 29% y/y to 320M » 06:02
10/29/20
10/29
06:02
10/29/20
06:02
SPOT

Spotify

$276.35 /

-11.34 (-3.94%)

The company said:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

10/27/20 Morgan Stanley
Spotify price target raised to $300 from $275 at Morgan Stanley
10/27/20 Deutsche Bank
Spotify price target raised to $250 from $240 at Deutsche Bank
10/14/20 Barclays
Spotify price target raised to $320 from $310 at Barclays
10/06/20 Credit Suisse
Sirius XM upgraded to Outperform from Neutral at Credit Suisse
SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

Earnings
Vontier reports Q3 EPS 80c, consensus 70c » 06:02
10/29/20
10/29
06:02
10/29/20
06:02
VNT

Vontier

$28.23 /

-0.53 (-1.84%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VNT Vontier
$28.23 /

-0.53 (-1.84%)

VNT Vontier
$28.23 /

-0.53 (-1.84%)

10/26/20 Baird
Vontier initiated with an Outperform at Baird
10/19/20 Rosenblatt
Fortive price target lowered to $68 from $81 at Rosenblatt
10/16/20 Credit Suisse
Vontier initiated with an Outperform at Credit Suisse
10/15/20 Wolfe Research
Vontier initiated with an Outperform at Wolfe Research
VNT Vontier
$28.23 /

-0.53 (-1.84%)

Upgrade
Chubb upgraded to Neutral from Underperform at BofA » 06:02
10/29/20
10/29
06:02
10/29/20
06:02
CB

Chubb

$127.34 /

+3.83 (+3.10%)

BofA upgraded Chubb to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CB Chubb
$127.34 /

+3.83 (+3.10%)

CB Chubb
$127.34 /

+3.83 (+3.10%)

10/12/20 JPMorgan
Chubb upgraded to Overweight from Neutral at JPMorgan
10/12/20 JPMorgan
Travelers downgraded to Underweight from Neutral at JPMorgan
07/16/20 Evercore ISI
Chubb upgraded to Outperform from In Line at Evercore ISI
07/07/20 Wells Fargo
Chubb price target raised to $150 from $142 at Wells Fargo
CB Chubb
$127.34 /

+3.83 (+3.10%)

CB Chubb
$127.34 /

+3.83 (+3.10%)

CB Chubb
$127.34 /

+3.83 (+3.10%)

CB Chubb
$127.34 /

+3.83 (+3.10%)

Earnings
Spotify reports Q3 EPS (EUR 0.58) vs. EUR 0.36 last year » 06:01
10/29/20
10/29
06:01
10/29/20
06:01
SPOT

Spotify

$276.35 /

-11.34 (-3.94%)

Reports Q3 revenue EUR…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

10/27/20 Morgan Stanley
Spotify price target raised to $300 from $275 at Morgan Stanley
10/27/20 Deutsche Bank
Spotify price target raised to $250 from $240 at Deutsche Bank
10/14/20 Barclays
Spotify price target raised to $320 from $310 at Barclays
10/06/20 Credit Suisse
Sirius XM upgraded to Outperform from Neutral at Credit Suisse
SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

Hot Stocks
Dr. Reddy's announces partnership with BIRAC for Sputnik V vaccine support » 06:01
10/29/20
10/29
06:01
10/29/20
06:01
RDY

Dr. Reddy's

$64.82 /

-3.34 (-4.90%)

Dr. Reddy's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDY Dr. Reddy's
$64.82 /

-3.34 (-4.90%)

RDY Dr. Reddy's
$64.82 /

-3.34 (-4.90%)

09/18/20 Investec
Dr. Reddy's upgraded to Hold from Sell at Investec
09/03/20 Oppenheimer
Opco 'more skeptical' on Amarin patent win after 20 minute court hearing
09/02/20 Goldman Sachs
Oral arguments incrementally negative for Amarin, says Goldman Sachs
08/10/20 Oppenheimer
Amarin Perform rating affirmed at Oppenheimer after FDA approves Vascepa generic
RDY Dr. Reddy's
$64.82 /

-3.34 (-4.90%)

RDY Dr. Reddy's
$64.82 /

-3.34 (-4.90%)

Hot Stocks
LKQ Corp. to resume share repurchase program in Q4  06:01
10/29/20
10/29
06:01
10/29/20
06:01
LKQ

LKQ Corp.

$29.81 /

-1.09 (-3.53%)

 
ShowHide Related Items >><<
LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

09/11/20 Jefferies
LKQ Corp. price target raised to $42 from $35 at Jefferies
09/08/20 Stephens
LKQ Corp. price target raised to $40 from $35 at Stephens
07/15/20 SunTrust
LKQ Corp price target raised to $35 from $30 at SunTrust
06/19/20 JPMorgan
LKQ Corp. price target raised to $32 from $29 at JPMorgan
LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

Earnings
LKQ Corp. reports Q3 adjusted EPS 75c, consensus 53c » 06:01
10/29/20
10/29
06:01
10/29/20
06:01
LKQ

LKQ Corp.

$29.81 /

-1.09 (-3.53%)

Reports Q3 revenue $3B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

09/11/20 Jefferies
LKQ Corp. price target raised to $42 from $35 at Jefferies
09/08/20 Stephens
LKQ Corp. price target raised to $40 from $35 at Stephens
07/15/20 SunTrust
LKQ Corp price target raised to $35 from $30 at SunTrust
06/19/20 JPMorgan
LKQ Corp. price target raised to $32 from $29 at JPMorgan
LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

Downgrade
First Solar downgraded to Neutral after 67% rally at JPMorgan » 06:00
10/29/20
10/29
06:00
10/29/20
06:00
FSLR

First Solar

$93.27 /

+10.89 (+13.22%)

JPMorgan analyst Paul…

JPMorgan analyst Paul Coster downgraded First Solar to Neutral from Overweight with an unchanged price target of $94. After rallying 67% year-to-date, the stock is now trading close to the price target and at "historically-elevated" multiples, Coster tells investors in a research note. At the current multiple, and entering a later stage of the Series 6 product transition, focus shifts from sequential improvement in margins and profitability as production capacity fills in to whether First Solar has established a sustainable energy-density and cost/watt advantage in the global solar industry, says the analyst.

ShowHide Related Items >><<
FSLR First Solar
$93.27 /

+10.89 (+13.22%)

FSLR First Solar
$93.27 /

+10.89 (+13.22%)

04:45 Today JPMorgan
First Solar downgraded to Neutral from Overweight at JPMorgan
10/28/20 Raymond James
First Solar price target raised to $90 from $80 at Raymond James
10/28/20 Roth Capital
First Solar price target raised to $110 from $100 at Roth Capital
10/28/20 Baird
First Solar price target raised to $125 from $97 at Baird
FSLR First Solar
$93.27 /

+10.89 (+13.22%)

  • 17
    Sep
FSLR First Solar
$93.27 /

+10.89 (+13.22%)

FSLR First Solar
$93.27 /

+10.89 (+13.22%)

Earnings
KBR raises FY20 adj. EPS view to $1.60-$1.80 from $1.50-$1.80, consensus $1.68 » 05:59
10/29/20
10/29
05:59
10/29/20
05:59
KBR

KBR

$22.42 /

-0.795 (-3.42%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBR KBR
$22.42 /

-0.795 (-3.42%)

KBR KBR
$22.42 /

-0.795 (-3.42%)

10/27/20 Citi
KBR price target raised to $30 from $28 at Citi
06/15/20 Citi
KBR price target raised to $29 from $25 at Citi
06/03/20 Goldman Sachs
KBR upgraded to Buy from Neutral at Goldman Sachs
06/03/20 Goldman Sachs
Wabtec downgraded to Neutral from Buy at Goldman Sachs
KBR KBR
$22.42 /

-0.795 (-3.42%)

KBR KBR
$22.42 /

-0.795 (-3.42%)

Periodicals
Amazon files motion to dismiss false advertising suit, Hollywood Reporter says » 05:59
10/29/20
10/29
05:59
10/29/20
05:59
AMZN

Amazon.com

$3,163.17 /

-123.35 (-3.75%)

Amazon has filed a motion…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,163.17 /

-123.35 (-3.75%)

AMZN Amazon.com
$3,163.17 /

-123.35 (-3.75%)

10/27/20 Credit Suisse
Amazon.com price target raised to $3,700 from $3,680 at Credit Suisse
10/27/20 KeyBanc
Tapestry price target raised to $27 from $20 at KeyBanc
10/27/20 Deutsche Bank
Amazon.com price target raised to $4,050 from $4,000 at Deutsche Bank
10/26/20 Wedbush
Wedbush expects Amazon to report Q3 sales upside, record Q4
AMZN Amazon.com
$3,163.17 /

-123.35 (-3.75%)

AMZN Amazon.com
$3,163.17 /

-123.35 (-3.75%)

AMZN Amazon.com
$3,163.17 /

-123.35 (-3.75%)

AMZN Amazon.com
$3,163.17 /

-123.35 (-3.75%)

AMZN Amazon.com
$3,163.17 /

-123.35 (-3.75%)

Downgrade
JPMorgan downgrades ChemoCentryx to Neutral after 'mixed' data » 05:58
10/29/20
10/29
05:58
10/29/20
05:58
CCXI

ChemoCentryx

$52.18 /

-0.26 (-0.50%)

JPMorgan analyst Anupam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCXI ChemoCentryx
$52.18 /

-0.26 (-0.50%)

CCXI ChemoCentryx
$52.18 /

-0.26 (-0.50%)

05:10 Today JPMorgan
ChemoCentryx downgraded to Neutral from Overweight at JPMorgan
04:52 Today Piper Sandler
ChemoCentryx price target raised to $71 from $67 at Piper Sandler
09/17/20 H.C. Wainwright
ChemoCentryx price target raised to $85 from $73 at H.C. Wainwright
09/17/20 Piper Sandler
ChemoCentryx target lowered to $67 at Piper Sandler on lower avacopan AAV sales
CCXI ChemoCentryx
$52.18 /

-0.26 (-0.50%)

  • 11
    Jun
CCXI ChemoCentryx
$52.18 /

-0.26 (-0.50%)

Earnings
KBR reports Q3 adj. EPS 44c, consensus 43c » 05:57
10/29/20
10/29
05:57
10/29/20
05:57
KBR

KBR

$22.42 /

-0.795 (-3.42%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KBR KBR
$22.42 /

-0.795 (-3.42%)

KBR KBR
$22.42 /

-0.795 (-3.42%)

10/27/20 Citi
KBR price target raised to $30 from $28 at Citi
06/15/20 Citi
KBR price target raised to $29 from $25 at Citi
06/03/20 Goldman Sachs
KBR upgraded to Buy from Neutral at Goldman Sachs
06/03/20 Goldman Sachs
Wabtec downgraded to Neutral from Buy at Goldman Sachs
KBR KBR
$22.42 /

-0.795 (-3.42%)

KBR KBR
$22.42 /

-0.795 (-3.42%)

Earnings
U.S. Concrete reports Q3 EPS $1.42, consensus 85c » 05:57
10/29/20
10/29
05:57
10/29/20
05:57
USCR

U.S. Concrete

$30.32 /

-2.83 (-8.54%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USCR U.S. Concrete
$30.32 /

-2.83 (-8.54%)

USCR U.S. Concrete
$30.32 /

-2.83 (-8.54%)

04/21/20
DA Davidson uncertain on recovery time for U.S. Concrete, cuts to Neutral
04/21/20 DA Davidson
U.S. Concrete downgraded to Neutral from Buy at DA Davidson
04/20/20 SunTrust
U.S. Concrete price target lowered to $19 from $45 at SunTrust
04/20/20 Sidoti
U.S. Concrete downgraded to Neutral from Buy at Sidoti
USCR U.S. Concrete
$30.32 /

-2.83 (-8.54%)

USCR U.S. Concrete
$30.32 /

-2.83 (-8.54%)

USCR U.S. Concrete
$30.32 /

-2.83 (-8.54%)

Hot Stocks
AbbVie presents upadacitinib data compared to placebo at EADV » 05:54
10/29/20
10/29
05:54
10/29/20
05:54
ABBV

AbbVie

$80.50 /

-2.19 (-2.65%)

Late-breaking data…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$80.50 /

-2.19 (-2.65%)

ABBV AbbVie
$80.50 /

-2.19 (-2.65%)

10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
10/23/20
Fly Intel: Pre-market Movers
10/23/20 Truist
AbbVie initiated with a Buy at Truist
10/20/20 Goldman Sachs
Galapagos downgraded to Sell from Neutral at Goldman Sachs
ABBV AbbVie
$80.50 /

-2.19 (-2.65%)

ABBV AbbVie
$80.50 /

-2.19 (-2.65%)

ABBV AbbVie
$80.50 /

-2.19 (-2.65%)

Upgrade
GB Group upgraded to Buy from Hold at Panmure Gordon » 05:47
10/29/20
10/29
05:47
10/29/20
05:47
GBGPF

GB Group

$0.00 /

+ (+0.00%)

Panmure Gordon analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GBGPF GB Group
$0.00 /

+ (+0.00%)

10/20/20 Berenberg
GB Group upgraded to Buy from Hold at Berenberg
10/12/20 Citi
Citi opens 'positive catalyst watch' on GB Group
10/07/20 Canaccord
GB Group upgraded to Buy from Hold at Canaccord
07/01/20 Panmure Gordon
GB Group downgraded to Hold from Buy at Panmure Gordon
Earnings
Nokia reports Q3 non-IFRS EPS EUR0.05 vs. EUR0.05 last year » 05:46
10/29/20
10/29
05:46
10/29/20
05:46
NOK

Nokia

$4.06 /

-0.18 (-4.25%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOK Nokia
$4.06 /

-0.18 (-4.25%)

NOK Nokia
$4.06 /

-0.18 (-4.25%)

10/12/20 SEB Equities
Nokia upgraded to Buy from Hold at SEB Equities
09/29/20 Credit Suisse
Nokia price target lowered to EUR 3.65 from EUR 4 at Credit Suisse
09/08/20 Raymond James
Nokia downgraded to Market Perform from Strong Buy at Raymond James
09/08/20 Raymond James
Nokia downgraded to Market Perform from Strong Buy at Raymond James
NOK Nokia
$4.06 /

-0.18 (-4.25%)

NOK Nokia
$4.06 /

-0.18 (-4.25%)

NOK Nokia
$4.06 /

-0.18 (-4.25%)

NOK Nokia
$4.06 /

-0.18 (-4.25%)

Downgrade
Beiersdorf downgraded to Hold from Buy at HSBC » 05:45
10/29/20
10/29
05:45
10/29/20
05:45
BDRFY

Beiersdorf

$0.00 /

+ (+0.00%)

HSBC analyst Jeremy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDRFY Beiersdorf
$0.00 /

+ (+0.00%)

10/12/20 Bernstein
Beiersdorf initiated with an Outperform at Bernstein
10/02/20 Deutsche Bank
Beiersdorf price target lowered to EUR 100 from EUR 110 at Deutsche Bank
09/30/20 Barclays
Beiersdorf price target raised to EUR 115 from EUR 114 at Barclays
09/29/20 Berenberg
Beiersdorf upgraded to Hold from Sell at Berenberg
Hot Stocks
Exxon Mobil maintains quarterly dividend at 87c per share » 05:43
10/29/20
10/29
05:43
10/29/20
05:43
XOM

Exxon Mobil

$31.57 /

-1.26 (-3.84%)

Exxon Mobil last night…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XOM Exxon Mobil
$31.57 /

-1.26 (-3.84%)

XOM Exxon Mobil
$31.57 /

-1.26 (-3.84%)

10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 Goldman Sachs
Exxon Mobil upgraded to Neutral from Sell at Goldman Sachs
10/07/20 Societe Generale
SBM Offshore upgraded to Buy from Hold at Societe Generale
09/23/20 Scotiabank
Exxon Mobil upgraded to Sector Perform from Underperform at Scotiabank
XOM Exxon Mobil
$31.57 /

-1.26 (-3.84%)

XOM Exxon Mobil
$31.57 /

-1.26 (-3.84%)

XOM Exxon Mobil
$31.57 /

-1.26 (-3.84%)

XOM Exxon Mobil
$31.57 /

-1.26 (-3.84%)

Hot Stocks
Moderna partners with Takeda to supply 50M doses of COVID-19 vaccine in Japan » 05:41
10/29/20
10/29
05:41
10/29/20
05:41
MRNA

Moderna

$65.75 /

-4.9 (-6.94%)

, TAK

Takeda Pharmaceutical

$16.11 /

-0.445 (-2.69%)

Moderna (MRNA) confirmed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$65.75 /

-4.9 (-6.94%)

TAK Takeda Pharmaceutical
$16.11 /

-0.445 (-2.69%)

MRNA Moderna
$65.75 /

-4.9 (-6.94%)

10/08/20 Piper Sandler
Moderna regains rights to adult RSV vaccine mRNA-1172, Piper ups target to $136
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/18/20 Needham
Moderna shares attractive long term on mRNA platform and pipeline, says Needham
09/17/20 Jefferies
Moderna COVID trial stats suggest late Oct. or Nov. for data, says Jefferies
TAK Takeda Pharmaceutical
$16.11 /

-0.445 (-2.69%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
MRNA Moderna
$65.75 /

-4.9 (-6.94%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$65.75 /

-4.9 (-6.94%)

TAK Takeda Pharmaceutical
$16.11 /

-0.445 (-2.69%)

MRNA Moderna
$65.75 /

-4.9 (-6.94%)

TAK Takeda Pharmaceutical
$16.11 /

-0.445 (-2.69%)

MRNA Moderna
$65.75 /

-4.9 (-6.94%)

TAK Takeda Pharmaceutical
$16.11 /

-0.445 (-2.69%)

Hot Stocks
Veon to sell Veon Armenia subsidiary to Team LLC » 05:38
10/29/20
10/29
05:38
10/29/20
05:38
VEON

Veon

$1.22 /

-0.045 (-3.57%)

Veon announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VEON Veon
$1.22 /

-0.045 (-3.57%)

VEON Veon
$1.22 /

-0.045 (-3.57%)

09/22/20 VTB Capital
Veon upgraded to Buy from Hold at VTB Capital
08/06/20 New Street
Veon downgraded to Neutral from Buy at New Street
07/23/20 UBS
Veon downgraded to Neutral from Buy at UBS
03/27/20 VTB Capital
Veon upgraded to Buy from Hold at VTB Capital
  • 22
    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.